Medicines shortages prompt fresh look at UK manufacturing
Repeated supply interruptions have moved onshoring from an industrial ambition to a clinical concern.
Persistent shortages in a small number of generic medicines have renewed interest in domestic manufacturing capacity.
Clinicians describe the practical cost as prescribing workarounds, patient anxiety and pharmacist time spent sourcing alternatives.
Industry groups argue that pricing policy for generics leaves little margin to justify UK production.
Published 30 August 2026
The briefing
Join the 50k+ health sector leaders
One email each weekday morning with the reporting, analysis and numbers that matter across the UK health sector.
More from the newsroom
New Hospital Programme timetable slips again as trusts wait on capital allocations
Eight schemes have moved into the next funding wave, leaving trust boards planning around ageing estate for another parliament.
Marcus Dovedale30 August 2026
Virtual wards settle into the model that suits them
After rapid expansion, providers are narrowing virtual ward use to the conditions where the evidence is strongest.
Dr Helen Cartwright30 August 2026
Electronic patient record rollouts hit contract friction in three regions
Procurement disputes and integration costs are pushing frontline digitisation deadlines beyond the original national target.
Priya Raman30 August 2026
Pharmacy first referrals rise as general practice reroutes demand
Community pharmacy is absorbing a growing share of minor illness consultations.
Eleanor Whitfield30 August 2026